Gudan Wan attenuates metabolic dysfunction-associated steatohepatitis by modulating autophagy and the Bcl-2/Caspase-3/Caspase-8 apoptotic axis
BackgroundMetabolic dysfunction-associated steatohepatitis (MASH) is a leading global cause of end-stage liver disease, with safe and effective therapies still lacking.